搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The American Journal of Managed Care
10 小时
FDA Quietly Removes Draft Guidance on Diversity in Clinical Trials Following Executive ...
The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...
STAT
23 小时
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
18 小时
2025 Medical Device Cybersecurity Trends: What Will Shape The Industry?
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
23 小时
Amid recalls, Minnesota medtech exec says she was pressured to disregard safety law
Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...
gastroenterologyadvisor
17 小时
The Science Behind Sleep Supplements: Clinical Guidance Amidst Regulatory Concerns
While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.
18 小时
on MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
MJBizDaily
14 小时
Marijuana cultivator Bright Green to file for bankruptcy protection
Marijuana cultivator Bright Green Corp. plans to file for Chapter 11 bankruptcy reorganization after an agreement with a ...
News Medical on MSN
6 小时
New FDA initiatives focus on medication safety for pregnant and nursing women
If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...
clinicaltrialsarena on MSN
22 小时
MindMed doses first subject in Phase III Panorama study of GAD tablet
MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...
17 小时
on MSN
Why ABBV Is Rallying Today
AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings ...
Opinion
9 小时
on MSN
Opinion
Why We Should Fear Trump Silencing Science – and What We Can Do About It
Every administration brings changes and new politics. But for the sake of America’s health, we can’t censor public health ...
19 小时
on MSN
AbbVie swings to Q4 loss amid Cerevel impact; sets in-line guidance
AbbVie (NYSE:ABBV) traded higher in the premarket on Friday after setting its 2025 earnings outlook in line with expectations ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈